BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
1.270
+0.020 (1.60%)
Feb 24, 2026, 10:32 AM EST - Market open
BioVie Analyst Ratings
Total Analysts
n/a
Consensus Rating
n/a
Price Target
n/a
Upside
n/a
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| ThinkEquity | ThinkEquity | Strong Buy Initiates $300 | Strong Buy | Initiates | $300 | +23,522.05% | Jul 1, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $1,200 → $500 | Buy | Maintains | $1,200 → $500 | +39,270.08% | Nov 30, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $1,100 | Buy | Reiterates | $1,100 | +86,514.17% | Aug 22, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $1,100 | Buy | Reiterates | $1,100 | +86,514.17% | Jul 18, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $1,100 | Buy | Reiterates | $1,100 | +86,514.17% | May 17, 2023 |
| Oppenheimer | Oppenheimer | Buy Reiterates $1,200 | Buy | Reiterates | $1,200 | +94,388.19% | May 17, 2023 |
| Oppenheimer | Oppenheimer | Buy Reiterates $1,200 | Buy | Reiterates | $1,200 | +94,388.19% | Feb 14, 2023 |
| EF Hutton | EF Hutton | Strong Buy Maintains $1,400 → $800 | Strong Buy | Maintains | $1,400 → $800 | +62,892.13% | Sep 28, 2022 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $700 | Buy | Initiates | $700 | +55,018.11% | Jul 22, 2022 |
| EF Hutton | EF Hutton | Strong Buy Maintains $900 → $1,400 | Strong Buy | Maintains | $900 → $1,400 | +110,136.22% | Mar 17, 2022 |
| Oppenheimer | Oppenheimer | Buy Initiates $900 | Buy | Initiates | $900 | +70,766.14% | Mar 15, 2022 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $5,000 → $2,700 | Strong Buy | Maintains | $5,000 → $2,700 | +212,498.43% | Nov 30, 2021 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $4,700 | Strong Buy | Initiates | $4,700 | +369,978.74% | Jan 15, 2021 |